Biodegradable Microparticles for Stable Active Substance Encapsulation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing encapsulation technologies for active substances result in persistent polymer particles, known as microplastics, due to non-biodegradable polymers used in forming polymer shells or particles, which persist over extended periods and are not easily degradable under ambient conditions.

Innovation Solution

Development of microparticles containing a water-immiscible active substance, encapsulated with a matrix of phospholipids, sterols, polypeptides, and optionally positively charged polysaccharides, capable of forming non-covalent interactions, which are designed to be biodegradable and stable, avoiding the formation of microplastics.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If polymer shells or polymer particles are used for encapsulation, then encapsulation stability and controlled release are achieved, but persistent microplastics are formed that do not degrade under ambient conditions

Engineering Contradiction:
Improveencapsulation stabilityVSAvoidmicroplastic persistence
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent changes the chemical composition parameters of the encapsulation material from conventional non-biodegradable polymers to a specific matrix comprising phospholipids (40-70 wt%), sterols (10-30 wt%), polypeptides (10-30 wt%), and optionally polysaccharides (5-20 wt%). This parameter change transforms the material from persistent to biodegradable while maintaining encapsulation functionality through non-covalent interactions among matrix components.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs a composite material system combining multiple biodegradable components (phospholipids, sterols, polypeptides, and polysaccharides) that work synergistically through non-covalent interactions. This composite approach provides both the structural stability needed for encapsulation and the biodegradability required to avoid microplastic persistence, resolving the contradiction between reliability and environmental harm.

Inventive Principle:
Principle #40Composite materials

2Object-generated harmful factors

If biodegradable materials are used for encapsulation, then environmental persistence is reduced, but encapsulation stability and controlled release performance may be compromised

Engineering Contradiction:
Improveenvironmental persistenceVSAvoidencapsulation stability
Core Design Contradiction:
Object-generated harmful factorsVSReliability

Solution Approach 1:

The patent incorporates stabilizing components (sterols and polypeptides) into the matrix formulation from the outset to pre-establish structural integrity. These components form non-covalent interactions with phospholipids and active substances during encapsulation, creating a stable structure that maintains its function throughout the intended release period before eventual biodegradation, thus preventing stability issues.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent optimizes the weight percentage parameters of each matrix component to achieve the desired balance. Phospholipids (40-70 wt%) provide the base structure, sterols (10-30 wt%) enhance stability and control release, and polypeptides (10-30 wt%) contribute to both stability and biodegradability. This precise parameter control ensures encapsulation reliability is maintained while preserving biodegradability.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The microparticles provide excellent release profiles and form stable formulations that degrade easily, preventing the persistence of microplastics and offering controlled release of active substances without environmental harm.

Implementation Method 1

an inorganic salt IS capable of interacting with at least one of the components i) to iv) via formation of non-covalent bonds

Methodology Applied
Scientific EffectNon-covalent interactions: Van der Waals Force

Implementation Method 2

designed to be biodegradable and stable, avoiding the formation of microplastics

Methodology Applied
Scientific EffectBiodegradation: Decomposition (biological)

Data Source

PatentUS20250000086A1New microparticles containing active substances
Publication Date: 2025.01.02 BASF SE
  • US20250000086A1 patent drawing

AI summary

Microparticle, wherein said microparticle contains one or more active substance, said one or more active substance being water immiscible, wherein said one or more active substance is liquid (at 21° C.) or dissolved in a non-aqueous solvent S that is immiscible with water, and wherein said microparticle contains i) at least one phospholipid PL, ii) at least one sterol ST, iii) at least one at least one polypeptide PP, iv) optionally at least one polysaccharide PS that is overall positively charged, and v) optionally an inorganic salt IS capable of interacting with at least one of the components i) to iv) via formation of non-covalent bonds.